Clinical Supply Manager

Aditum Bio•Oakland, CA

13h

About The Position

At Aditum Bio, our mission is to rapidly translate scientific discoveries into new medicines. Co-founded by industry veterans Joe Jimenez, former CEO of Novartis and Mark Fishman, former President of the Novartis Institutes for Biomedical Research, the firm in-licenses promising therapies and advances them into Phase 1 and Phase 2 clinical studies to enable proof of concept. The firm focuses on the translational phase of medicine to generate data that can support full clinical development, and eventual market launch, to reach patients in need. The Clinical Supply Manager will lead clinical supply planning, forecasting, packaging, labeling, distribution, and inventory management activities across Aditum Bio's portfolio companies. Reporting to the SVP of CMC, this individual will work cross-functionally with portfolio company teams, external manufacturing partners, CROs, depots, and clinical development/operations groups to ensure uninterrupted supply of investigational products throughout clinical development. The role requires strong operational execution, proactive risk management, and the ability to support multiple programs at varying stages of development.

Requirements

Bachelor's degree in Life Sciences, Engineering, Supply Chain, or related discipline; advanced degree preferred.
5+ years of experience in clinical supply chain, clinical manufacturing operations, or pharmaceutical/biotech supply management.
Experience working in emerging biotech companies and/or supporting multiple development programs simultaneously.
Experience supporting Phase I/II clinical trials, including forecasting, packaging, labeling, distribution, and inventory management.
Demonstrated experience managing external vendors, CMOs, depots, and logistics providers.
Strong understanding of GxP requirements and clinical supply chain regulations.
Excellent project management, organizational, and communication skills.
Ability to operate independently in a fast-paced, highly collaborative environment with competing priorities.

Nice To Haves

advanced degree preferred

Responsibilities

Lead end-to-end clinical supply planning activities across portfolio companies and phases of development.
Ensure supply plans align with program timelines, enrollment assumptions, and development objectives.
Support clinical trial material production and distribution activities.
Support manufacturing campaigns, packaging runs, labeling activities, shipment planning, and global distribution of investigational products and ancillary supplies.
Development and implement strategies to ensure study blinding requirements are met.
Manage clinical supply forecasting and inventory oversight.
Create and maintain demand forecasts, inventory plans, and supply scenarios for investigational product and for any comparators and/or auxiliary items required to support study execution while minimizing waste, shortages, and excess inventory.
Ensure accurate tracking of inventory, shipments, forecasts, and supply performance indicators while supporting inspection readiness and compliance requirements.
Identify and mitigate supply risks by proactively assessing potential supply chain constraints, manufacturing risks, and inventory vulnerabilities, and developing contingency plans to maintain uninterrupted clinical trial support.
Coordinate external supply chain partners and vendors.
Serve as the primary operational liaison for CMOs, packaging and labeling vendors, depots, IRT providers, and logistics partners to ensure timely and compliant supply execution.
Collaborate closely with cross-functional stakeholders.
Partner with Manufacturing, Clinical Development/Operations, Regulatory Affairs, Quality Assurance, and portfolio company leadership teams to align clinical supply activities with broader program objectives.
Contribute to process development across the Aditum Bio portfolio.
Help establish scalable clinical supply planning practices, vendor management frameworks, and operational standards that can be leveraged across multiple portfolio companies.